Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, 01239, USA.
Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA, 02139, USA.
Adv Mater. 2024 Oct;36(43):e2303301. doi: 10.1002/adma.202303301. Epub 2023 Jul 19.
Soft robotic technologies for therapeutic biomedical applications require conformal and atraumatic tissue coupling that is amenable to dynamic loading for effective drug delivery or tissue stimulation. This intimate and sustained contact offers vast therapeutic opportunities for localized drug release. Herein, a new class of hybrid hydrogel actuator (HHA) that facilitates enhanced drug delivery is introduced. The multi-material soft actuator can elicit a tunable mechanoresponsive release of charged drug from its alginate/acrylamide hydrogel layer with temporal control. Dosing control parameters include actuation magnitude, frequency, and duration. The actuator can safely adhere to tissue via a flexible, drug-permeable adhesive bond that can withstand dynamic device actuation. Conformal adhesion of the hybrid hydrogel actuator to tissue leads to improved mechanoresponsive spatial delivery of the drug. Future integration of this hybrid hydrogel actuator with other soft robotic assistive technologies can enable a synergistic, multi-pronged treatment approach for the treatment of disease.
用于治疗生物医学应用的软机器人技术需要顺应性和无创伤性的组织耦联,以适应动态加载,从而实现有效的药物输送或组织刺激。这种亲密和持续的接触为局部药物释放提供了广阔的治疗机会。本文介绍了一种新的混合水凝胶驱动器(HHA),它可以促进增强型药物输送。这种多材料软驱动器可以从其海藻酸盐/丙烯酰胺水凝胶层中引出可调的机械响应释放带电荷的药物,并具有时间控制。给药控制参数包括致动幅度、频率和持续时间。该驱动器可以通过柔性、药物渗透的粘合剂安全地粘附在组织上,该粘合剂可以承受动态设备致动。混合水凝胶驱动器与组织的顺应性粘附导致药物的机械响应空间传递得到改善。未来将这种混合水凝胶驱动器与其他软机器人辅助技术集成,可以为疾病治疗提供协同的、多管齐下的治疗方法。